{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T12:14:09Z","timestamp":1790252049740,"version":"4.1.0"},"reference-count":124,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,19]],"date-time":"2024-08-19T00:00:00Z","timestamp":1724025600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,8,19]],"date-time":"2024-08-19T00:00:00Z","timestamp":1724025600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virol J"],"DOI":"10.1186\/s12985-024-02450-7","type":"journal-article","created":{"date-parts":[[2024,8,19]],"date-time":"2024-08-19T11:02:35Z","timestamp":1724065355000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["The potential use of bacteriophages as antibacterial agents against Klebsiella pneumoniae"],"prefix":"10.1186","volume":"21","author":[{"given":"Omid","family":"Gholizadeh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hadi Esmaeili Gouvarchin","family":"Ghaleh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahdi","family":"Tat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Ranjbar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruhollah","family":"Dorostkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,19]]},"reference":[{"key":"2450_CR1","doi-asserted-by":"crossref","unstructured":"Wu M, Li X. Klebsiella pneumoniae and Pseudomonas aeruginosa, in molecular medical microbiology. Elsevier; 2015. pp. 1547\u201364.","DOI":"10.1016\/B978-0-12-397169-2.00087-1"},{"issue":"1","key":"2450_CR2","first-page":"15","volume":"71","author":"A Cruz-C\u00f3rdova","year":"2014","unstructured":"Cruz-C\u00f3rdova A, et al. Pathogenic determinants of clinical Klebsiella pneumoniae strains associated with their persistence in the hospital environment. Bolet\u00edn m\u00e9dico Del Hosp Infantil De M\u00e9xico. 2014;71(1):15\u201324.","journal-title":"Bolet\u00edn m\u00e9dico Del Hosp Infantil De M\u00e9xico"},{"issue":"10","key":"2450_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/nmicrobiol.2016.187","volume":"1","author":"R Sugden","year":"2016","unstructured":"Sugden R, Kelly R, Davies S. Combatting antimicrobial resistance globally. Nat Microbiol. 2016;1(10):1\u20132.","journal-title":"Nat Microbiol"},{"issue":"7","key":"2450_CR4","doi-asserted-by":"publisher","first-page":"934","DOI":"10.3390\/jcm8070934","volume":"8","author":"N Petrosillo","year":"2019","unstructured":"Petrosillo N, Taglietti F, Granata G. Treatment options for colistin resistant Klebsiella pneumoniae: present and future. J Clin Med. 2019;8(7):934.","journal-title":"J Clin Med"},{"issue":"10","key":"2450_CR5","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1080\/14787210.2018.1522249","volume":"16","author":"M Bassetti","year":"2018","unstructured":"Bassetti M, et al. Multidrug-resistant Klebsiella pneumoniae: challenges for treatment, prevention and infection control. Expert Rev anti-infective Therapy. 2018;16(10):749\u201361.","journal-title":"Expert Rev anti-infective Therapy"},{"issue":"10442","key":"2450_CR6","doi-asserted-by":"publisher","first-page":"2426","DOI":"10.1016\/S0140-6736(24)00876-6","volume":"403","author":"IN Okeke","year":"2024","unstructured":"Okeke IN, et al. The scope of the antimicrobial resistance challenge. Lancet. 2024;403(10442):2426\u201338.","journal-title":"Lancet"},{"key":"2450_CR7","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1146\/annurev-med-080219-122208","volume":"73","author":"GF Hatfull","year":"2022","unstructured":"Hatfull GF, Dedrick RM, Schooley RT. Phage therapy for antibiotic-resistant bacterial infections. Annu Rev Med. 2022;73:197\u2013211.","journal-title":"Annu Rev Med"},{"issue":"5","key":"2450_CR8","doi-asserted-by":"publisher","first-page":"e3002119","DOI":"10.1371\/journal.pbio.3002119","volume":"21","author":"A Petrovic Fabijan","year":"2023","unstructured":"Petrovic Fabijan A, et al. Translating phage therapy into the clinic: recent accomplishments but continuing challenges. PLoS Biol. 2023;21(5):e3002119.","journal-title":"PLoS Biol"},{"key":"2450_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40168-021-01026-9","volume":"9","author":"A Mu","year":"2021","unstructured":"Mu A, et al. Assessment of the microbiome during bacteriophage therapy in combination with systemic antibiotics to treat a case of staphylococcal device infection. Microbiome. 2021;9:1\u20138.","journal-title":"Microbiome"},{"issue":"3","key":"2450_CR10","doi-asserted-by":"publisher","first-page":"e31698","DOI":"10.1371\/journal.pone.0031698","volume":"7","author":"J Gu","year":"2012","unstructured":"Gu J, et al. A method for generation phage cocktail with great therapeutic potential. PLoS ONE. 2012;7(3):e31698.","journal-title":"PLoS ONE"},{"issue":"1","key":"2450_CR11","doi-asserted-by":"publisher","first-page":"2458","DOI":"10.1038\/s41598-022-06422-1","volume":"12","author":"F Molina","year":"2022","unstructured":"Molina F, et al. Systematic analysis of putative phage-phage interactions on minimum-sized phage cocktails. Sci Rep. 2022;12(1):2458.","journal-title":"Sci Rep"},{"key":"2450_CR12","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.cis.2017.05.014","volume":"249","author":"DJ Malik","year":"2017","unstructured":"Malik DJ, et al. Formulation, stabilisation and encapsulation of bacteriophage for phage therapy. Adv Colloid Interface Sci. 2017;249:100\u201333.","journal-title":"Adv Colloid Interface Sci"},{"key":"2450_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12985-020-01485-w","volume":"18","author":"F Zurabov","year":"2021","unstructured":"Zurabov F, Zhilenkov E. Characterization of four virulent Klebsiella pneumoniae bacteriophages, and evaluation of their potential use in complex phage preparation. Virol J. 2021;18:1\u201320.","journal-title":"Virol J"},{"issue":"4","key":"2450_CR14","doi-asserted-by":"publisher","first-page":"00012","DOI":"10.1128\/mmbr","volume":"83","author":"K D\u0105browska","year":"2019","unstructured":"D\u0105browska K, Abedon ST. Pharmacologically aware phage therapy: pharmacodynamic and pharmacokinetic obstacles to phage antibacterial action in animal and human bodies. Microbiol Mol Biol Rev. 2019;83(4):00012\u201319. https:\/\/doi.org\/10.1128\/mmbr.","journal-title":"Microbiol Mol Biol Rev"},{"key":"2450_CR15","doi-asserted-by":"publisher","first-page":"106218","DOI":"10.1016\/j.micpath.2023.106218","volume":"182","author":"B Liang","year":"2023","unstructured":"Liang B, et al. Effective of phage cocktail against Klebsiella pneumoniae infection of murine mammary glands. Microb Pathog. 2023;182:106218.","journal-title":"Microb Pathog"},{"key":"2450_CR16","doi-asserted-by":"crossref","unstructured":"Martins WM, et al. Effective phage cocktail to combat the rising incidence of extensively drug-resistant Klebsiella pneumoniae sequence type 16. Volume 11. Emerging Microbes & Infections; 2022. pp. 1015\u201323. 1.","DOI":"10.1080\/22221751.2022.2051752"},{"key":"2450_CR17","doi-asserted-by":"crossref","unstructured":"Yoo S et al. Designing phage cocktails to combat the emergence of bacteriophage-resistant mutants in multidrug-resistant Klebsiella pneumoniae. Microbiol Spectr, 2023: p. e01258\u201323.","DOI":"10.1128\/spectrum.01258-23"},{"key":"2450_CR18","doi-asserted-by":"crossref","unstructured":"Jokar J et al. Antibacterial effects of single phage and phage cocktail against multidrug-resistant Klebsiella pneumoniae isolated from diabetic foot ulcer. Virus Genes, 2023: p. 1\u20138.","DOI":"10.1007\/s11262-023-02004-z"},{"key":"2450_CR19","doi-asserted-by":"crossref","unstructured":"\u0141usiak-Szelachowska M, Weber-D\u0105browska B, \u017baczek M. The Presence of Bacteriophages in the Human Body: Good, Bad or Neutral? 2020. 8(12).","DOI":"10.3390\/microorganisms8122012"},{"key":"2450_CR20","doi-asserted-by":"crossref","unstructured":"Salih Do\u011fan H et al. Two novel phages, Klebsiella phage GADU21 and Escherichia phage GADU22, from the urine samples of patients with urinary tract infection Virus Genes, 2024: pp. 1\u201314.","DOI":"10.1007\/s11262-024-02052-z"},{"key":"2450_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12941-019-0343-8","volume":"19","author":"CY Effah","year":"2020","unstructured":"Effah CY, et al. Klebsiella pneumoniae: an increasing threat to public health. Ann Clin Microbiol Antimicrob. 2020;19:1\u20139.","journal-title":"Ann Clin Microbiol Antimicrob"},{"issue":"4","key":"2450_CR22","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1128\/CMR.05035-11","volume":"25","author":"L Tzouvelekis","year":"2012","unstructured":"Tzouvelekis L, et al. Carbapenemases in Klebsiella pneumoniae and other Enterobacteriaceae: an evolving crisis of global dimensions. Clin Microbiol Rev. 2012;25(4):682\u2013707.","journal-title":"Clin Microbiol Rev"},{"issue":"18","key":"2450_CR23","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1056\/NEJMoa1801550","volume":"379","author":"SS Magill","year":"2018","unstructured":"Magill SS, et al. Changes in prevalence of health care\u2013associated infections in US hospitals. N Engl J Med. 2018;379(18):1732\u201344.","journal-title":"N Engl J Med"},{"issue":"2","key":"2450_CR24","doi-asserted-by":"publisher","first-page":"78","DOI":"10.3390\/biology13020078","volume":"13","author":"R Abbas","year":"2024","unstructured":"Abbas R, et al. General Overview of Klebsiella pneumonia: epidemiology and the role of Siderophores in its pathogenicity. Biology. 2024;13(2):78.","journal-title":"Biology"},{"key":"2450_CR25","doi-asserted-by":"publisher","first-page":"102135","DOI":"10.1016\/j.nantod.2023.102135","volume":"54","author":"L Jiang","year":"2024","unstructured":"Jiang L, et al. Single-dose of hybrid eukaryotic-prokaryotic nanovesicles to drive a rapid and controllable immune response against Klebsiella pneumoniae induced nosocomial pneumonia. Nano Today. 2024;54:102135.","journal-title":"Nano Today"},{"issue":"3","key":"2450_CR26","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1128\/MMBR.00078-15","volume":"80","author":"MK Paczosa","year":"2016","unstructured":"Paczosa MK, Mecsas J. Klebsiella pneumoniae: going on the offense with a strong defense. Microbiol Mol Biol Rev. 2016;80(3):629\u201361.","journal-title":"Microbiol Mol Biol Rev"},{"issue":"2","key":"2450_CR27","doi-asserted-by":"publisher","first-page":"234","DOI":"10.3390\/antibiotics12020234","volume":"12","author":"T Karampatakis","year":"2023","unstructured":"Karampatakis T, Tsergouli K, Behzadi P. Carbapenem-resistant Klebsiella pneumoniae: virulence factors, molecular epidemiology and latest updates in treatment options. Antibiotics. 2023;12(2):234.","journal-title":"Antibiotics"},{"issue":"17","key":"2450_CR28","doi-asserted-by":"publisher","first-page":"6278","DOI":"10.3390\/ijerph17176278","volume":"17","author":"G Wang","year":"2020","unstructured":"Wang G, et al. The characteristic of virulence, Biofilm and Antibiotic Resistance of Klebsiella pneumoniae. Int J Environ Res Public Health. 2020;17(17):6278.","journal-title":"Int J Environ Res Public Health"},{"key":"2450_CR29","doi-asserted-by":"crossref","unstructured":"Teo T-H et al. Differential mucosal tropism and dissemination of classical and hypervirulent Klebsiella pneumoniae infection. iScience, 2024.","DOI":"10.1016\/j.isci.2024.108875"},{"issue":"3","key":"2450_CR30","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.mimet.2005.03.018","volume":"63","author":"A Carattoli","year":"2005","unstructured":"Carattoli A, et al. Identification of plasmids by PCR-based replicon typing. J Microbiol Methods. 2005;63(3):219\u201328.","journal-title":"J Microbiol Methods"},{"issue":"3","key":"2450_CR31","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1093\/femsre\/fux013","volume":"41","author":"S Navon-Venezia","year":"2017","unstructured":"Navon-Venezia S, Kondratyeva K, Carattoli A. Klebsiella pneumoniae: a major worldwide source and shuttle for antibiotic resistance. FEMS Microbiol Rev. 2017;41(3):252\u201375.","journal-title":"FEMS Microbiol Rev"},{"key":"2450_CR32","doi-asserted-by":"crossref","unstructured":"Martin MJ et al. A panel of diverse Klebsiella pneumoniae clinical isolates for research and development. Microb Genomics, 2023. 9(5).","DOI":"10.1099\/mgen.0.000967"},{"issue":"9","key":"2450_CR33","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.2217\/fmb.14.48","volume":"9","author":"B Li","year":"2014","unstructured":"Li B, et al. Molecular pathogenesis of Klebsiella pneumoniae. Future Microbiol. 2014;9(9):1071\u201381.","journal-title":"Future Microbiol"},{"issue":"6","key":"2450_CR34","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1038\/s41579-019-0315-1","volume":"18","author":"KL Wyres","year":"2020","unstructured":"Wyres KL, Lam MM, Holt KE. Population genomics of Klebsiella pneumoniae. Nat Rev Microbiol. 2020;18(6):344\u201359.","journal-title":"Nat Rev Microbiol"},{"key":"2450_CR35","doi-asserted-by":"crossref","unstructured":"Pu Q, et al. Know your enemy: Klebsiella pneumoniae, in Molecular Medical Microbiology. Elsevier; 2024. pp. 1491\u2013501.","DOI":"10.1016\/B978-0-12-818619-0.00101-5"},{"key":"2450_CR36","doi-asserted-by":"publisher","first-page":"167373","DOI":"10.1016\/j.scitotenv.2023.167373","volume":"906","author":"H Yao","year":"2024","unstructured":"Yao H, et al. Conjugative plasmids facilitate the transmission of tmexCD2-toprJ2 among carbapenem-resistant Klebsiella pneumoniae. Sci Total Environ. 2024;906:167373.","journal-title":"Sci Total Environ"},{"issue":"1","key":"2450_CR37","first-page":"e310323215266","volume":"17","author":"O Albarri","year":"2024","unstructured":"Albarri O, et al. Antimicrobial Resistance of Clinical Klebsiella pneumoniae isolates: involvement of AcrAB and OqxAB Efflux Pumps. Curr Mol Pharmacol. 2024;17(1):e310323215266.","journal-title":"Curr Mol Pharmacol"},{"key":"2450_CR38","unstructured":"Gorodnichev R et al. ISOLATION AND CHARACTERIZATION OF VIRULENT BACTERIOPHAGES AGAINST KLEBSIELLA PNEUMONIAE OF SIGNIFICANT CAPSULAR TYPES"},{"key":"2450_CR39","doi-asserted-by":"crossref","unstructured":"Behera B et al. Genotypic characterization of hypervirulent Klebsiella pneumoniae (hvKp) in a tertiary care Indian hospital. Int Microbiol, 2024: p. 1\u201310.","DOI":"10.1007\/s10123-024-00480-3"},{"issue":"2","key":"2450_CR40","doi-asserted-by":"publisher","first-page":"253","DOI":"10.3390\/microorganisms12020253","volume":"12","author":"J Fletcher","year":"2024","unstructured":"Fletcher J, et al. The Citizen Phage Library: Rapid isolation of phages for the Treatment of Antibiotic Resistant Infections in the UK. Microorganisms. 2024;12(2):253.","journal-title":"Microorganisms"},{"key":"2450_CR41","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.coviro.2021.11.005","volume":"52","author":"G Verbeken","year":"2022","unstructured":"Verbeken G, Pirnay J-P. European regulatory aspects of phage therapy: magistral phage preparations. Curr Opin Virol. 2022;52:24\u20139.","journal-title":"Curr Opin Virol"},{"issue":"10","key":"2450_CR42","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.3390\/ph14101019","volume":"14","author":"ST Abedon","year":"2021","unstructured":"Abedon ST, Danis-Wlodarczyk KM, Wozniak DJ. Phage cocktail development for bacteriophage therapy: toward improving spectrum of activity breadth and depth. Pharmaceuticals. 2021;14(10):1019.","journal-title":"Pharmaceuticals"},{"key":"2450_CR43","doi-asserted-by":"publisher","first-page":"100042","DOI":"10.1016\/j.glmedi.2023.100042","volume":"2","author":"BA Ogungbe","year":"2024","unstructured":"Ogungbe BA, et al. Progress of phage therapy research as an alternative to antibiotics: current status, challenges, and the future of phage therapeutics. J Med Surg Public Health. 2024;2:100042.","journal-title":"J Med Surg Public Health"},{"issue":"2","key":"2450_CR44","first-page":"66","volume":"4","author":"T Rose","year":"2014","unstructured":"Rose T, et al. Experimental phage therapy of burn wound infection: difficult first steps. Int J Burns Trauma. 2014;4(2):66.","journal-title":"Int J Burns Trauma"},{"issue":"9","key":"2450_CR45","doi-asserted-by":"publisher","first-page":"2326","DOI":"10.1093\/jac\/dku173","volume":"69","author":"TM Viertel","year":"2014","unstructured":"Viertel TM, Ritter K, Horz H-P. Viruses versus bacteria\u2014novel approaches to phage therapy as a tool against multidrug-resistant pathogens. J Antimicrob Chemother. 2014;69(9):2326\u201336.","journal-title":"J Antimicrob Chemother"},{"issue":"5","key":"2450_CR46","first-page":"671","volume":"13","author":"Y Elahi","year":"2021","unstructured":"Elahi Y, Nowroozi J, Fard RMN. Isolation and characterization of bacteriophages from wastewater sources on Enterococcus spp. isolated from clinical samples. Iran J Microbiol. 2021;13(5):671\u20137.","journal-title":"Iran J Microbiol"},{"key":"2450_CR47","doi-asserted-by":"crossref","unstructured":"Hitchcock NM. and D. Devequi Gomes Nunes. Curr Clin Landsc Global Potential Bacteriophage Therapy 2023. 15(4).","DOI":"10.3390\/v15041020"},{"key":"2450_CR48","doi-asserted-by":"crossref","unstructured":"Hyman P. Phages for phage therapy: isolation, characterization, and host range breadth. Pharmaceuticals (Basel), 2019. 12(1).","DOI":"10.3390\/ph12010035"},{"key":"2450_CR49","doi-asserted-by":"crossref","unstructured":"Van Twest R, Kropinski AM. Bacteriophage enrichment from water and soil Bacteriophages: Methods and Protocols, Volume 1: Isolation, Characterization, and Interactions, 2009: pp. 15\u201321.","DOI":"10.1007\/978-1-60327-164-6_2"},{"key":"2450_CR50","doi-asserted-by":"crossref","unstructured":"Abedon ST et al. Phage therapy: past, present and future. 2017, Front Media SA. p. 981.","DOI":"10.3389\/978-2-88945-251-4"},{"key":"2450_CR51","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.3389\/fmicb.2015.01271","volume":"6","author":"S Mattila","year":"2015","unstructured":"Mattila S, Ruotsalainen P, Jalasvuori M. On-demand isolation of bacteriophages against drug-resistant bacteria for personalized phage therapy. Front Microbiol. 2015;6:1271.","journal-title":"Front Microbiol"},{"key":"2450_CR52","first-page":"934","volume":"7","author":"Z Wang","year":"2016","unstructured":"Wang Z, et al. SLPW: a virulent bacteriophage targeting methicillin-resistant Staphylococcus aureus in vitro and in vivo. Front Microbiol. 2016;7:934.","journal-title":"Front Microbiol"},{"key":"2450_CR53","doi-asserted-by":"crossref","unstructured":"Bhetwal A et al. Isolation of potential phages against multidrug-resistant bacterial isolates: promising agents in the rivers of Kathmandu, Nepal BioMed Research International, 2017. 2017.","DOI":"10.1155\/2017\/3723254"},{"issue":"2","key":"2450_CR54","doi-asserted-by":"publisher","first-page":"86","DOI":"10.4161\/bact.1.2.15456","volume":"1","author":"B Anderson","year":"2011","unstructured":"Anderson B, et al. Enumeration of bacteriophage particles: comparative analysis of the traditional plaque assay and real-time QPCR- and nanosight-based assays. Bacteriophage. 2011;1(2):86\u201393.","journal-title":"Bacteriophage"},{"issue":"1","key":"2450_CR55","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1038\/s41598-023-50823-9","volume":"14","author":"KA Mirza","year":"2024","unstructured":"Mirza KA, et al. Bacteriophage-mediated decolonization of Klebsiella pneumoniae in a novel Galleria mellonella gut colonization model with Enterobacteriaceae. Sci Rep. 2024;14(1):318.","journal-title":"Sci Rep"},{"key":"2450_CR56","doi-asserted-by":"publisher","first-page":"574","DOI":"10.3389\/fmicb.2019.00574","volume":"10","author":"P Manohar","year":"2019","unstructured":"Manohar P, et al. Therapeutic characterization and efficacy of bacteriophage cocktails infecting Escherichia coli, Klebsiella pneumoniae, and Enterobacter species. Front Microbiol. 2019;10:574.","journal-title":"Front Microbiol"},{"key":"2450_CR57","doi-asserted-by":"publisher","first-page":"135148","DOI":"10.1016\/j.snb.2023.135148","volume":"403","author":"R Liu","year":"2024","unstructured":"Liu R, et al. Bacteriophage long tail fibre proteins as a biorecognition element in electrochemical biosensors for the detection of Salmonella in lake water. Sens Actuators B. 2024;403:135148.","journal-title":"Sens Actuators B"},{"issue":"1","key":"2450_CR58","doi-asserted-by":"publisher","first-page":"5254","DOI":"10.1038\/s41467-023-41075-2","volume":"14","author":"M Yan","year":"2023","unstructured":"Yan M, et al. Interrogating the viral dark matter of the rumen ecosystem with a global virome database. Nat Commun. 2023;14(1):5254.","journal-title":"Nat Commun"},{"key":"2450_CR59","doi-asserted-by":"crossref","unstructured":"Kareem ZG, Al-Zamily, Al-Khafaji NS. Purification and characterization of \u03b1-galactosidase isolated from Klebsiella pneumoniae in the human oral cavity. Int J Biol Macromol, 2024: p. 129550.","DOI":"10.1016\/j.ijbiomac.2024.129550"},{"key":"2450_CR60","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1007\/s00284-009-9430-y","volume":"59","author":"V Verma","year":"2009","unstructured":"Verma V, Harjai K, Chhibber S. Characterization of a T7-like lytic bacteriophage of Klebsiella pneumoniae B5055: a potential therapeutic agent. Curr Microbiol. 2009;59:274\u201381.","journal-title":"Curr Microbiol"},{"issue":"9","key":"2450_CR61","doi-asserted-by":"publisher","first-page":"482","DOI":"10.3390\/v10090482","volume":"10","author":"N Ciacci","year":"2018","unstructured":"Ciacci N, et al. Characterization of vB_Kpn_F48, a newly discovered lytic bacteriophage for Klebsiella pneumoniae of sequence type 101. Viruses. 2018;10(9):482.","journal-title":"Viruses"},{"issue":"12","key":"2450_CR62","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.3390\/v11121115","volume":"11","author":"V Morozova","year":"2019","unstructured":"Morozova V, et al. Isolation and characterization of a novel Klebsiella pneumoniae N4-like bacteriophage KP8. Viruses. 2019;11(12):1115.","journal-title":"Viruses"},{"key":"2450_CR63","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1007\/s00253-011-3149-y","volume":"90","author":"Z Drulis-Kawa","year":"2011","unstructured":"Drulis-Kawa Z, et al. Isolation and characterisation of KP34\u2014a novel \u03c6KMV-like bacteriophage for Klebsiella pneumoniae. Appl Microbiol Biotechnol. 2011;90:1333\u201345.","journal-title":"Appl Microbiol Biotechnol"},{"issue":"1\u20132","key":"2450_CR64","first-page":"6","volume":"7","author":"MS Sasani","year":"2019","unstructured":"Sasani MS, Eftekhar F, Hosseini SM. Isolation and characterization of Klebsiella pneumoniae specific lytic bacteriophage from. J Med Microbiol. 2019;7(1\u20132):6\u201311.","journal-title":"J Med Microbiol"},{"key":"2450_CR65","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/s00284-012-0264-7","volume":"66","author":"N Karumidze","year":"2013","unstructured":"Karumidze N, et al. Isolation and characterisation of lytic bacteriophages of Klebsiella pneumoniae and Klebsiella oxytoca. Curr Microbiol. 2013;66:251\u20138.","journal-title":"Curr Microbiol"},{"issue":"11","key":"2450_CR66","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1093\/infdis\/jiu332","volume":"210","author":"T-L Lin","year":"2014","unstructured":"Lin T-L, et al. Isolation of a bacteriophage and its depolymerase specific for K1 capsule of Klebsiella pneumoniae: implication in typing and treatment. J Infect Dis. 2014;210(11):1734\u201344.","journal-title":"J Infect Dis"},{"key":"2450_CR67","doi-asserted-by":"crossref","unstructured":"Duarte J et al. Potential of a New Bacteriophage to Control Klebsiella pneumoniae: Preliminary Studies to Control Urinary Tract Infections 2024.","DOI":"10.20944\/preprints202401.0492.v1"},{"key":"2450_CR68","doi-asserted-by":"publisher","first-page":"100515","DOI":"10.1016\/j.ijmmb.2023.100515","volume":"47","author":"S Shree","year":"2024","unstructured":"Shree S, et al. Effect of Klebsiella-specific phage on multidrug-resistant Klebsiella pneumoniae-an experimental study. Ind J Med Microbiol. 2024;47:100515.","journal-title":"Ind J Med Microbiol"},{"key":"2450_CR69","doi-asserted-by":"crossref","unstructured":"Ferriol-Gonzalez C et al. Targeted phage hunting to specific Klebsiella pneumoniae clinical isolates is an efficient antibiotic resistance and infection control strategy bioRxiv, 2024: p. 2024.01. 07.574526.","DOI":"10.1101\/2024.01.07.574526"},{"key":"2450_CR70","doi-asserted-by":"crossref","unstructured":"Feng Y et al. Safety and efficacy of a phage cocktail on murine wound infections caused by carbapenem-resistant Klebsiella pneumoniae. Int J Antimicrob Agents, 2024: p. 107088.","DOI":"10.1016\/j.ijantimicag.2024.107088"},{"key":"2450_CR71","doi-asserted-by":"publisher","first-page":"1227147","DOI":"10.3389\/fmicb.2023.1227147","volume":"14","author":"C Chen","year":"2023","unstructured":"Chen C, et al. Isolation and characterization of novel bacteriophage vB_KpP_HS106 for Klebsiella pneumonia K2 and applications in foods. Front Microbiol. 2023;14:1227147.","journal-title":"Front Microbiol"},{"key":"2450_CR72","doi-asserted-by":"crossref","unstructured":"Cao F et al. Evaluation of the efficacy of a bacteriophage in the treatment of pneumonia induced by multidrug resistance Klebsiella pneumoniae in mice BioMed Research International, 2015. 2015.","DOI":"10.1155\/2015\/752930"},{"issue":"12","key":"2450_CR73","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1099\/jmm.0.2008\/002873-0","volume":"57","author":"S Chhibber","year":"2008","unstructured":"Chhibber S, Kaur S, Kumari S. Therapeutic potential of bacteriophage in treating Klebsiella pneumoniae B5055-mediated lobar pneumonia in mice. J Med Microbiol. 2008;57(12):1508\u201313.","journal-title":"J Med Microbiol"},{"issue":"8","key":"2450_CR74","doi-asserted-by":"publisher","first-page":"e70092","DOI":"10.1371\/journal.pone.0070092","volume":"8","author":"C-R Hsu","year":"2013","unstructured":"Hsu C-R, et al. Isolation of a bacteriophage specific for a new capsular type of Klebsiella pneumoniae and characterization of its polysaccharide depolymerase. PLoS ONE. 2013;8(8):e70092.","journal-title":"PLoS ONE"},{"key":"2450_CR75","doi-asserted-by":"publisher","unstructured":"Hesse S et al. Bacteriophage treatment rescues mice infected with multidrug-resistant Klebsiella pneumoniae ST258 MBio, 2021. 12(1): p. https:\/\/doi.org\/10.1128\/mbio. 00034\u2009\u2013\u200921.","DOI":"10.1128\/mbio"},{"issue":"1","key":"2450_CR76","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12985-020-01485-w","volume":"18","author":"F Zurabov","year":"2021","unstructured":"Zurabov F, Zhilenkov E. Characterization of four virulent Klebsiella pneumoniae bacteriophages, and evaluation of their potential use in complex phage preparation. Virol J. 2021;18(1):1\u201320.","journal-title":"Virol J"},{"key":"2450_CR77","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1743-422X-10-100","volume":"10","author":"A K\u0119sik-Szeloch","year":"2013","unstructured":"K\u0119sik-Szeloch A, et al. Characterising the biology of novel lytic bacteriophages infecting multidrug resistant Klebsiella pneumoniae. Virol J. 2013;10:1\u201312.","journal-title":"Virol J"},{"key":"2450_CR78","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.3389\/fmicb.2018.02127","volume":"9","author":"OA Taha","year":"2018","unstructured":"Taha OA, et al. Bacteriophage ZCKP1: a potential treatment for Klebsiella pneumoniae isolated from diabetic foot patients. Front Microbiol. 2018;9:2127.","journal-title":"Front Microbiol"},{"key":"2450_CR79","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.jgar.2019.09.018","volume":"21","author":"T Anand","year":"2020","unstructured":"Anand T, et al. Phage therapy for treatment of virulent Klebsiella pneumoniae infection in a mouse model. J Global Antimicrob Resist. 2020;21:34\u201341.","journal-title":"J Global Antimicrob Resist"},{"issue":"12","key":"2450_CR80","doi-asserted-by":"publisher","first-page":"e16011","DOI":"10.1016\/j.cmi.2023.08.022","volume":"29","author":"J Li","year":"2023","unstructured":"Li J, et al. Development of phage resistance in multidrug-resistant Klebsiella pneumoniae is associated with reduced virulence: a case report of a personalised phage therapy. Clin Microbiol Infect. 2023;29(12):e16011\u20137.","journal-title":"Clin Microbiol Infect"},{"key":"2450_CR81","doi-asserted-by":"crossref","unstructured":"Singh D et al. Characterization and complete genome analysis of Klebsiella phage Kp109 with lytic activity against Klebsiella pneumoniae. Virus Genes, 2024: p. 1\u201313.","DOI":"10.1007\/s11262-024-02053-y"},{"issue":"4","key":"2450_CR82","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1128\/AAC.01123-10","volume":"55","author":"C-H Hung","year":"2011","unstructured":"Hung C-H, et al. Experimental phage therapy in treating Klebsiella pneumoniae-mediated liver abscesses and bacteremia in mice. Antimicrob Agents Chemother. 2011;55(4):1358\u201365.","journal-title":"Antimicrob Agents Chemother"},{"key":"2450_CR83","doi-asserted-by":"crossref","unstructured":"Louren\u00e7o M et al. Phages against Noncapsulated Klebsiella pneumoniae: Broader Host range, Slower Resistance Microbiology Spectrum, 2023: pp. e04812-22.","DOI":"10.1101\/2022.08.04.502604"},{"key":"2450_CR84","doi-asserted-by":"publisher","first-page":"1156292","DOI":"10.3389\/fmicb.2023.1156292","volume":"14","author":"M Tang","year":"2023","unstructured":"Tang M, et al. Phage resistance formation and fitness costs of hypervirulent Klebsiella pneumoniae mediated by K2 capsule-specific phage and the corresponding mechanisms. Front Microbiol. 2023;14:1156292.","journal-title":"Front Microbiol"},{"issue":"2","key":"2450_CR85","doi-asserted-by":"publisher","first-page":"195","DOI":"10.3390\/antibiotics13020195","volume":"13","author":"J Duarte","year":"2024","unstructured":"Duarte J, et al. Potential of an isolated bacteriophage to inactivate Klebsiella pneumoniae: preliminary studies to control urinary tract infections. Antibiotics. 2024;13(2):195.","journal-title":"Antibiotics"},{"issue":"null","key":"2450_CR86","doi-asserted-by":"publisher","first-page":"449","DOI":"10.2147\/IDR.S451013","volume":"17","author":"R Bai","year":"2024","unstructured":"Bai R, Guo J. Interactions and implications of Klebsiella pneumoniae with Human Immune responses and metabolic pathways: a Comprehensive Review. Infect Drug Resist. 2024;17(null):449\u201362.","journal-title":"Infect Drug Resist"},{"issue":"1","key":"2450_CR87","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s12941-023-00567-1","volume":"22","author":"M Mohammadi","year":"2023","unstructured":"Mohammadi M, et al. Isolation, characterization, therapeutic potency, and genomic analysis of a novel bacteriophage vB_KshKPC-M against carbapenemase-producing Klebsiella pneumoniae strains (CRKP) isolated from Ventilator-associated pneumoniae (VAP) infection of COVID-19 patients. Ann Clin Microbiol Antimicrob. 2023;22(1):18.","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"2450_CR88","unstructured":"Wei H et al. Phage: Tackling Drug-Resistant Klebsiella Pneumoniae Available at SSRN 4713374."},{"issue":"1","key":"2450_CR89","first-page":"e00954","volume":"13","author":"T Bird Jordan","year":"2023","unstructured":"Bird Jordan T, et al. Genome sequence of the Klebsiella quasipneumoniae bacteriophage EKq1 with activity against Klebsiella pneumoniae. Microbiol Resource Announcements. 2023;13(1):e00954\u201323.","journal-title":"Microbiol Resource Announcements"},{"issue":"6","key":"2450_CR90","first-page":"e01994","volume":"10","author":"S Mulani Mansura","year":"2022","unstructured":"Mulani Mansura S, Shital NK, Pardesi Karishma R. Characterization of Novel Klebsiella Phage PG14 and its Antibiofilm Efficacy. Microbiol Spectr. 2022;10(6):e01994\u201322.","journal-title":"Microbiol Spectr"},{"key":"2450_CR91","doi-asserted-by":"publisher","first-page":"1077995","DOI":"10.3389\/fcimb.2023.1077995","volume":"13","author":"BM Zaki","year":"2023","unstructured":"Zaki BM, et al. Characterization and comprehensive genome analysis of novel bacteriophage, vB_Kpn_ZCKp20p, with lytic and anti-biofilm potential against clinical multidrug-resistant Klebsiella pneumoniae. Front Cell Infect Microbiol. 2023;13:1077995.","journal-title":"Front Cell Infect Microbiol"},{"issue":"1","key":"2450_CR92","doi-asserted-by":"publisher","first-page":"15188","DOI":"10.1038\/s41598-023-42505-3","volume":"13","author":"F Zurabov","year":"2023","unstructured":"Zurabov F, et al. Bacteriophages with depolymerase activity in the control of antibiotic resistant Klebsiella pneumoniae biofilms. Sci Rep. 2023;13(1):15188.","journal-title":"Sci Rep"},{"issue":"1","key":"2450_CR93","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1038\/s41467-021-27656-z","volume":"13","author":"A Eskenazi","year":"2022","unstructured":"Eskenazi A, et al. Combination of pre-adapted bacteriophage therapy and antibiotics for treatment of fracture-related infection due to pandrug-resistant Klebsiella pneumoniae. Nat Commun. 2022;13(1):302.","journal-title":"Nat Commun"},{"key":"2450_CR94","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1007\/s11274-009-9991-8","volume":"25","author":"MS Bedi","year":"2009","unstructured":"Bedi MS, Verma V, Chhibber S. Amoxicillin and specific bacteriophage can be used together for eradication of biofilm of Klebsiella pneumoniae B5055. World J Microbiol Biotechnol. 2009;25:1145\u201351.","journal-title":"World J Microbiol Biotechnol"},{"issue":"6","key":"2450_CR95","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1093\/jac\/dkp360","volume":"64","author":"V Verma","year":"2009","unstructured":"Verma V, Harjai K, Chhibber S. Restricting ciprofloxacin-induced resistant variant formation in biofilm of Klebsiella pneumoniae B5055 by complementary bacteriophage treatment. J Antimicrob Chemother. 2009;64(6):1212\u20138.","journal-title":"J Antimicrob Chemother"},{"issue":"6","key":"2450_CR96","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1080\/08927014.2010.511196","volume":"26","author":"V Verma","year":"2010","unstructured":"Verma V, Harjai K, Chhibber S. Structural changes induced by a lytic bacteriophage make ciprofloxacin effective against older biofilm of Klebsiella pneumoniae. Biofouling. 2010;26(6):729\u201337.","journal-title":"Biofouling"},{"key":"2450_CR97","doi-asserted-by":"crossref","unstructured":"Qurat-ul-Ain H et al. Efficacy of phage-antibiotic combinations against multidrug-resistant Klebsiella pneumoniae clinical isolates. Jundishapur J Microbiol, 2021. 14(1).","DOI":"10.5812\/jjm.111926"},{"issue":"3","key":"2450_CR98","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1128\/AAC.45.3.649-659.2001","volume":"45","author":"A Sulakvelidze","year":"2001","unstructured":"Sulakvelidze A, Alavidze Z, Morris JG Jr. Bacteriophage therapy. Antimicrob Agents Chemother. 2001;45(3):649\u201359.","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"2450_CR99","doi-asserted-by":"publisher","first-page":"672","DOI":"10.3390\/antibiotics10060672","volume":"10","author":"A Broncano-Lavado","year":"2021","unstructured":"Broncano-Lavado A, et al. Advances in bacteriophage therapy against relevant multidrug-resistant pathogens. Antibiotics. 2021;10(6):672.","journal-title":"Antibiotics"},{"issue":"4","key":"2450_CR100","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.3390\/v15041020","volume":"15","author":"NM Hitchcock","year":"2023","unstructured":"Hitchcock NM, et al. Current Clinical Landscape and global potential of bacteriophage therapy. Viruses. 2023;15(4):1020.","journal-title":"Viruses"},{"issue":"4","key":"2450_CR101","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1080\/21597081.2016.1251379","volume":"6","author":"A Aleshkin","year":"2016","unstructured":"Aleshkin A, et al. Phagebiotics in treatment and prophylaxis of healthcare-associated infections. Bacteriophage. 2016;6(4):40\u20136.","journal-title":"Bacteriophage"},{"key":"2450_CR102","doi-asserted-by":"publisher","first-page":"35","DOI":"10.20953\/1729-9225-2017-1-35-40","volume":"15","author":"S Bochkareva","year":"2017","unstructured":"Bochkareva S, et al. Anti-phage \u0430ntibody response in phage therapy against healthcare-associated infections (HAIs). Infekc Bolezni. 2017;15:35\u201340.","journal-title":"Infekc Bolezni"},{"issue":"1","key":"2450_CR103","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/S1473-3099(18)30482-1","volume":"19","author":"P Jault","year":"2019","unstructured":"Jault P, et al. Efficacy and tolerability of a cocktail of bacteriophages to treat burn wounds infected by Pseudomonas aeruginosa (PhagoBurn): a randomised, controlled, double-blind phase 1\/2 trial. Lancet Infect Dis. 2019;19(1):35\u201345.","journal-title":"Lancet Infect Dis"},{"key":"2450_CR104","doi-asserted-by":"publisher","first-page":"608402","DOI":"10.3389\/fcimb.2020.608402","volume":"10","author":"J Qin","year":"2021","unstructured":"Qin J, et al. Heterogeneous Klebsiella pneumoniae co-infections complicate personalized bacteriophage therapy. Front Cell Infect Microbiol. 2021;10:608402.","journal-title":"Front Cell Infect Microbiol"},{"issue":"1","key":"2450_CR105","doi-asserted-by":"publisher","first-page":"e144","DOI":"10.1093\/cid\/ciaa705","volume":"73","author":"EJ Cano","year":"2021","unstructured":"Cano EJ, et al. Phage therapy for limb-threatening prosthetic knee Klebsiella pneumoniae infection: case report and in vitro characterization of anti-biofilm activity. Clin Infect Dis. 2021;73(1):e144\u201351.","journal-title":"Clin Infect Dis"},{"key":"2450_CR106","doi-asserted-by":"crossref","unstructured":"Bao J, et al. Non-active antibiotic and bacteriophage synergism to successfully treat recurrent urinary tract infection caused by extensively drug-resistant Klebsiella pneumoniae. Volume 9. Emerging microbes & infections; 2020. pp. 771\u20134. 1.","DOI":"10.1080\/22221751.2020.1747950"},{"issue":"4","key":"2450_CR107","doi-asserted-by":"publisher","first-page":"dsab013","DOI":"10.1093\/dnares\/dsab013","volume":"28","author":"B Estrada Bonilla","year":"2021","unstructured":"Estrada Bonilla B, et al. Genomic characterization of four novel bacteriophages infecting the clinical pathogen Klebsiella pneumoniae. DNA Res. 2021;28(4):dsab013.","journal-title":"DNA Res"},{"issue":"2","key":"2450_CR108","doi-asserted-by":"publisher","first-page":"425","DOI":"10.3390\/ijms21020425","volume":"21","author":"P Domingo-Calap","year":"2020","unstructured":"Domingo-Calap P, et al. Isolation of four lytic phages infecting Klebsiella pneumoniae K22 clinical isolates from Spain. Int J Mol Sci. 2020;21(2):425.","journal-title":"Int J Mol Sci"},{"issue":"11","key":"2450_CR109","doi-asserted-by":"publisher","first-page":"2252","DOI":"10.3390\/microorganisms9112252","volume":"9","author":"AT Marques","year":"2021","unstructured":"Marques AT, et al. Genomic analysis of prophages from Klebsiella pneumoniae clinical isolates. Microorganisms. 2021;9(11):2252.","journal-title":"Microorganisms"},{"issue":"1","key":"2450_CR110","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1177\/1534734619881076","volume":"20","author":"DR Patel","year":"2021","unstructured":"Patel DR, et al. Use of customized bacteriophages in the treatment of chronic nonhealing wounds: a prospective study. Int J Low Extrem Wounds. 2021;20(1):37\u201346.","journal-title":"Int J Low Extrem Wounds"},{"key":"2450_CR111","doi-asserted-by":"publisher","first-page":"674068","DOI":"10.3389\/fmicb.2021.674068","volume":"12","author":"Z Wang","year":"2021","unstructured":"Wang Z, et al. Combination therapy of phage vB_KpnM_P-KP2 and gentamicin combats acute pneumonia caused by K47 serotype Klebsiella pneumoniae. Front Microbiol. 2021;12:674068.","journal-title":"Front Microbiol"},{"key":"2450_CR112","doi-asserted-by":"publisher","unstructured":"Pacios O, et al. Enhanced antibacterial activity of repurposed mitomycin C and imipenem in combination with the lytic phage vB_KpnM-VAC13 against clinical isolates of Klebsiella pneumoniae. Antimicrob Agents Chemother. 2021;65(9). https:\/\/doi.org\/10.1128\/aac. 00900\u2009\u2013\u200921.","DOI":"10.1128\/aac"},{"issue":"1","key":"2450_CR113","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1186\/s12879-023-08621-1","volume":"23","author":"G Mboowa","year":"2023","unstructured":"Mboowa G. Reviewing the journey to the clinical application of bacteriophages to treat multi-drug-resistant bacteria. BMC Infect Dis. 2023;23(1):654.","journal-title":"BMC Infect Dis"},{"key":"2450_CR114","unstructured":"Onallah H, Hazan R, Nir-Paz R. Compassionate use of bacteriophages for failed persistent infections during the first 5 years of the Israeli phage Therapy Center. Open Forum Infectious diseases. Oxford University Press US; 2023."},{"issue":"1","key":"2450_CR115","doi-asserted-by":"publisher","first-page":"28","DOI":"10.3390\/biology13010028","volume":"13","author":"A Jiang","year":"2024","unstructured":"Jiang A, et al. Prospects and challenges of Bacteriophage Substitution for antibiotics in Livestock and Poultry Production. Biology. 2024;13(1):28.","journal-title":"Biology"},{"key":"2450_CR116","first-page":"1099","volume-title":"Clinical trials of bacteriophage therapeutics","author":"S McCallin","year":"2021","unstructured":"McCallin S, Br\u00fcssow H. Clinical trials of bacteriophage therapeutics. Bacteriophages: Biology, Technology, Therapy,; 2021. pp. 1099\u2013127."},{"issue":"7790","key":"2450_CR117","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/s41586-019-1894-8","volume":"577","author":"HG Hampton","year":"2020","unstructured":"Hampton HG, Watson BN, Fineran PC. The arms race between bacteria and their phage foes. Nature. 2020;577(7790):327\u201336.","journal-title":"Nature"},{"issue":"16","key":"2450_CR118","doi-asserted-by":"publisher","first-page":"2879","DOI":"10.1016\/j.cell.2022.07.003","volume":"185","author":"S Federici","year":"2022","unstructured":"Federici S, et al. Targeted suppression of human IBD-associated gut microbiota commensals by phage consortia for treatment of intestinal inflammation. Cell. 2022;185(16):2879\u201398. e24.","journal-title":"Cell"},{"key":"2450_CR119","doi-asserted-by":"publisher","first-page":"631794","DOI":"10.3389\/fmicb.2021.631794","volume":"12","author":"S Penziner","year":"2021","unstructured":"Penziner S, Schooley RT, Pride DT. Animal models of phage therapy. Front Microbiol. 2021;12:631794.","journal-title":"Front Microbiol"},{"issue":"1","key":"2450_CR120","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1080\/1040841X.2020.1729695","volume":"46","author":"LD Melo","year":"2020","unstructured":"Melo LD, et al. Phage therapy efficacy: a review of the last 10 years of preclinical studies. Crit Rev Microbiol. 2020;46(1):78\u201399.","journal-title":"Crit Rev Microbiol"},{"issue":"12","key":"2450_CR121","doi-asserted-by":"publisher","first-page":"e0243947","DOI":"10.1371\/journal.pone.0243947","volume":"15","author":"KE Macdonald","year":"2020","unstructured":"Macdonald KE, et al. Patient perceptions of phage therapy for diabetic foot infection. PLoS ONE. 2020;15(12):e0243947.","journal-title":"PLoS ONE"},{"key":"2450_CR122","doi-asserted-by":"crossref","unstructured":"Ali Y et al. The current status of phage therapy and its advancement towards establishing standard antimicrobials for combating multi drug-resistant bacterial pathogens Microbial Pathogenesis, 2023: p. 106199.","DOI":"10.1016\/j.micpath.2023.106199"},{"key":"2450_CR123","doi-asserted-by":"crossref","unstructured":"Zalewska-Pi\u0105tek B. Phage Therapy-Challenges, opportunities and Future prospects. Pharmaceuticals (Basel), 2023. 16(12).","DOI":"10.3390\/ph16121638"},{"key":"2450_CR124","doi-asserted-by":"crossref","unstructured":"Gan L et al. Bacteriophage effectively rescues Pneumonia caused by prevalent multidrug-resistant Klebsiella pneumoniae in the early stage. 2022. 10(5): p. e0235822.","DOI":"10.1128\/spectrum.02358-22"}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-024-02450-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12985-024-02450-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-024-02450-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,19]],"date-time":"2024-08-19T12:05:27Z","timestamp":1724069127000},"score":1,"resource":{"primary":{"URL":"https:\/\/virologyj.biomedcentral.com\/articles\/10.1186\/s12985-024-02450-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,19]]},"references-count":124,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["2450"],"URL":"https:\/\/doi.org\/10.1186\/s12985-024-02450-7","relation":{},"ISSN":["1743-422X"],"issn-type":[{"value":"1743-422X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,19]]},"assertion":[{"value":"6 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"O.G., H.E.G., M.T., R.R., R.D., writing\u2013original draft. All authors participated in the manuscript in the critical review process of the manuscript and approved the final version.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Credit authorship contribution statement"}}],"article-number":"191"}}